// App-Quantinova.ai

156 2015 ATVB : Development of a New Bioactivatable Fluorescent Probe for the Study of the Proteolytic Activities Degrading Apolipoprotein A-I in vitro and in vivo

Researchers

Presenter

  • Baoqiang Li

Principal Investigators

  • Catherine Gebhard

  • Mathieu Brodeur

  • Louis Villeneuve

  • Frederic Lesage

  • David Rhainds

  • Eric Rheaume

  • Jean Claude Tardif

Medical Centers

  • Inst of Biomedical Engineering, Montreal, QC, Canada

  • Montreal Heart Institute, Montreal, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • Apolipoprotein A-I

  • Cathepsin S

Drug/Treatment

  • Cysteine Hydrochloride

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim